EVOK Evoke Pharma Inc.


29,683 Shares Traded
106,696 Average Volume (last 30 days)

as of March 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:11.91%
If Intiated One Month Ago, Shorts Have Realized a Return of:0.96%
If Initiated Five Days ago, Shorts Have Realized a Return of:-0.49%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.94%
Short Interest885.52 thousand
Float14.9 million
Short Ratio7.53
Market Cap$32.07 million
Market Maker ActivityDaily Short Volume


Key events next week - healthcare (SeekingAlpha)
Premarket analyst action - healthcare (continued) (SeekingAlpha)
Evoke Pharma's (EVOK) CEO Dave Gonyer on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
Evoke Pharma beats by $0.16 (SeekingAlpha)
Notable earnings after Wednesday's close (SeekingAlpha)
Your Daily Pharma Scoop: AbbVie's Upadacitinib, Johnson & Johnson's Tremfya, Celgene Reports Results For Otezla (SeekingAlpha)
Evoke's planned FDA submission for Gimoti extended to next quarter; shares down 11% on women-only indication (SeekingAlpha)
Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2017 Results - Earnings Call Transcript (SeekingAlpha)
Evoke Pharma misses by $0.14 (SeekingAlpha)
Notable earnings after Tuesday's close (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 11.1%

Earnings Stats

PE Ratio -2.38
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $2.62
50 Day Moving Average $2.29
52 Week High $4.09
52 Week Low $1.85

Data provided for free by IEX. Questions? Read the FAQ